Vyne Therapeutics Inc.
13F holders, Q1 2024 (March 31)2holders
$3.07avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Vyne Therapeutics Inc. in their 13F filings. The largest holders were Staley Capital Advisers Inc. ($112K) and Cornerstone Planning Group LLC ($6).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6 |
| Exits | 0 | $0 |
Ownership 2 holders
| Staley Capital Advisers Inc. | 0.01% | No change | 36,472 | $112K |
| Cornerstone Planning Group LLC | 0.00% | New | 2 | $6 |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.